Free Trial

FibroGen (FGEN) SEC Filings & 10K Form

FibroGen logo
$0.28 -0.01 (-4.86%)
Closing price 04/4/2025 04:00 PM Eastern
Extended Trading
$0.29 +0.01 (+3.93%)
As of 04/4/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent FibroGen SEC Filings

DateFilerForm TypeView
03/28/2025
4:20 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
8:00 AM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
8:00 AM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:15 PM
FibroGen (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
6:01 PM
DeLucia David (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
6:02 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
6:03 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
4:19 PM
FibroGen (Filer)
Form 424B5
02/24/2025
4:22 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
6:00 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:49 PM
ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
Form SCHEDULE 13G/A
02/13/2025
5:24 PM
FibroGen (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SCHEDULE 13G/A
01/10/2025
5:15 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
5:16 PM
DeLucia David (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
4:01 PM
DeLucia David (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
8:15 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
7:00 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:00 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:00 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:52 PM
ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
Form SC 13G/A
11/12/2024
1:33 PM
FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
11:11 AM
FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/03/2024
3:05 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
7:00 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
7:00 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
7:00 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:05 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
4:10 PM
FibroGen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/10/2024
11:15 PM
FibroGen (Filer)
Form EFFECT
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
FibroGen (Subject)
Form SC 13G/A
06/28/2024
4:08 PM
FibroGen (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/26/2024
7:00 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:30 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:30 PM
Adib Deyaa (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:37 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:00 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:00 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:12 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
7:00 PM
Blaug Suzanne (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
EDWARDS JEFFREY L (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
Brennan Aoife (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This almost killed Elon Musk (chilling details emerge) (Ad)

Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.

See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro
06/06/2024
7:00 PM
Cravatt Benjamin (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
FibroGen (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
FibroGen (Issuer)
Lema Gerald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
6:46 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
8:55 PM
FibroGen (Filer)
Form ARS
04/24/2024
4:01 PM
FibroGen (Filer)
Form DEF 14A
04/24/2024
4:08 PM
FibroGen (Filer)
Form DEFA14A
04/24/2024
3:15 PM
Adib Deyaa (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:FGEN) was last updated on 4/5/2025 by MarketBeat.com Staff
From Our Partners